nodes	percent_of_prediction	percent_of_DWPC	metapath
Amoxapine—Loss of consciousness—Hydrocortisone—psoriasis	0.000922	0.00103	CcSEcCtD
Amoxapine—Thrombocytopenia—Mycophenolate mofetil—psoriasis	0.00092	0.00103	CcSEcCtD
Amoxapine—Anorexia—Cyclosporine—psoriasis	0.000918	0.00102	CcSEcCtD
Amoxapine—Pancreatitis—Methotrexate—psoriasis	0.000918	0.00102	CcSEcCtD
Amoxapine—Tachycardia—Mycophenolate mofetil—psoriasis	0.000917	0.00102	CcSEcCtD
Amoxapine—Alopecia—Dexamethasone—psoriasis	0.00091	0.00101	CcSEcCtD
Amoxapine—Alopecia—Betamethasone—psoriasis	0.00091	0.00101	CcSEcCtD
Amoxapine—Convulsion—Hydrocortisone—psoriasis	0.000909	0.00101	CcSEcCtD
Amoxapine—Hypertension—Hydrocortisone—psoriasis	0.000906	0.00101	CcSEcCtD
Amoxapine—Vomiting—Hydroxyurea—psoriasis	0.000904	0.00101	CcSEcCtD
Amoxapine—Rash—Hydroxyurea—psoriasis	0.000897	0.000999	CcSEcCtD
Amoxapine—Anorexia—Mycophenolate mofetil—psoriasis	0.000896	0.000998	CcSEcCtD
Amoxapine—Dermatitis—Hydroxyurea—psoriasis	0.000896	0.000998	CcSEcCtD
Amoxapine—Hallucination—Prednisone—psoriasis	0.000892	0.000994	CcSEcCtD
Amoxapine—Headache—Hydroxyurea—psoriasis	0.000891	0.000993	CcSEcCtD
Amoxapine—Syncope—Triamcinolone—psoriasis	0.000886	0.000987	CcSEcCtD
Amoxapine—Hypotension—Mycophenolate mofetil—psoriasis	0.000878	0.000979	CcSEcCtD
Amoxapine—Oedema—Prednisolone—psoriasis	0.000877	0.000977	CcSEcCtD
Amoxapine—Insomnia—Cyclosporine—psoriasis	0.000872	0.000971	CcSEcCtD
Amoxapine—Loss of consciousness—Triamcinolone—psoriasis	0.000868	0.000967	CcSEcCtD
Amoxapine—Paraesthesia—Cyclosporine—psoriasis	0.000865	0.000964	CcSEcCtD
Amoxapine—Shock—Prednisolone—psoriasis	0.000863	0.000961	CcSEcCtD
Amoxapine—Erectile dysfunction—Methotrexate—psoriasis	0.000862	0.000961	CcSEcCtD
Amoxapine—Somnolence—Cyclosporine—psoriasis	0.000857	0.000954	CcSEcCtD
Amoxapine—Oedema—Hydrocortisone—psoriasis	0.000856	0.000954	CcSEcCtD
Amoxapine—Convulsion—Triamcinolone—psoriasis	0.000856	0.000954	CcSEcCtD
Amoxapine—Tachycardia—Prednisolone—psoriasis	0.000856	0.000953	CcSEcCtD
Amoxapine—Asthenia—Mycophenolic acid—psoriasis	0.000855	0.000952	CcSEcCtD
Amoxapine—Hypertension—Triamcinolone—psoriasis	0.000853	0.00095	CcSEcCtD
Amoxapine—Insomnia—Mycophenolate mofetil—psoriasis	0.00085	0.000947	CcSEcCtD
Amoxapine—Dyspepsia—Cyclosporine—psoriasis	0.000848	0.000945	CcSEcCtD
Amoxapine—Nausea—Hydroxyurea—psoriasis	0.000845	0.000941	CcSEcCtD
Amoxapine—Paraesthesia—Mycophenolate mofetil—psoriasis	0.000844	0.00094	CcSEcCtD
Amoxapine—Pruritus—Mycophenolic acid—psoriasis	0.000843	0.000939	CcSEcCtD
Amoxapine—Shock—Hydrocortisone—psoriasis	0.000843	0.000939	CcSEcCtD
Amoxapine—Decreased appetite—Cyclosporine—psoriasis	0.000838	0.000933	CcSEcCtD
Amoxapine—Tachycardia—Hydrocortisone—psoriasis	0.000836	0.000931	CcSEcCtD
Amoxapine—Somnolence—Mycophenolate mofetil—psoriasis	0.000836	0.000931	CcSEcCtD
Amoxapine—Drowsiness—Methotrexate—psoriasis	0.000835	0.00093	CcSEcCtD
Amoxapine—Fatigue—Cyclosporine—psoriasis	0.000831	0.000926	CcSEcCtD
Amoxapine—Dyspepsia—Mycophenolate mofetil—psoriasis	0.000827	0.000922	CcSEcCtD
Amoxapine—Constipation—Cyclosporine—psoriasis	0.000824	0.000918	CcSEcCtD
Amoxapine—Dry mouth—Triamcinolone—psoriasis	0.000823	0.000916	CcSEcCtD
Amoxapine—Decreased appetite—Mycophenolate mofetil—psoriasis	0.000817	0.00091	CcSEcCtD
Amoxapine—Anorexia—Hydrocortisone—psoriasis	0.000816	0.000909	CcSEcCtD
Amoxapine—Diarrhoea—Mycophenolic acid—psoriasis	0.000815	0.000908	CcSEcCtD
Amoxapine—Stomatitis—Methotrexate—psoriasis	0.000814	0.000907	CcSEcCtD
Amoxapine—Oedema—Triamcinolone—psoriasis	0.000806	0.000898	CcSEcCtD
Amoxapine—Syncope—Dexamethasone—psoriasis	0.000804	0.000896	CcSEcCtD
Amoxapine—Syncope—Betamethasone—psoriasis	0.000804	0.000896	CcSEcCtD
Amoxapine—Constipation—Mycophenolate mofetil—psoriasis	0.000804	0.000896	CcSEcCtD
Amoxapine—Hypotension—Hydrocortisone—psoriasis	0.0008	0.000892	CcSEcCtD
Amoxapine—Feeling abnormal—Cyclosporine—psoriasis	0.000794	0.000885	CcSEcCtD
Amoxapine—Shock—Triamcinolone—psoriasis	0.000793	0.000884	CcSEcCtD
Amoxapine—Insomnia—Prednisolone—psoriasis	0.000793	0.000884	CcSEcCtD
Amoxapine—Alopecia—Prednisone—psoriasis	0.000793	0.000883	CcSEcCtD
Amoxapine—Gastrointestinal pain—Cyclosporine—psoriasis	0.000788	0.000878	CcSEcCtD
Amoxapine—Loss of consciousness—Dexamethasone—psoriasis	0.000788	0.000878	CcSEcCtD
Amoxapine—Loss of consciousness—Betamethasone—psoriasis	0.000788	0.000878	CcSEcCtD
Amoxapine—Dizziness—Mycophenolic acid—psoriasis	0.000788	0.000877	CcSEcCtD
Amoxapine—Paraesthesia—Prednisolone—psoriasis	0.000787	0.000877	CcSEcCtD
Amoxapine—Tachycardia—Triamcinolone—psoriasis	0.000787	0.000877	CcSEcCtD
Amoxapine—Agranulocytosis—Methotrexate—psoriasis	0.000779	0.000868	CcSEcCtD
Amoxapine—Convulsion—Dexamethasone—psoriasis	0.000777	0.000865	CcSEcCtD
Amoxapine—Convulsion—Betamethasone—psoriasis	0.000777	0.000865	CcSEcCtD
Amoxapine—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000775	0.000863	CcSEcCtD
Amoxapine—Insomnia—Hydrocortisone—psoriasis	0.000775	0.000863	CcSEcCtD
Amoxapine—Hypertension—Dexamethasone—psoriasis	0.000774	0.000862	CcSEcCtD
Amoxapine—Hypertension—Betamethasone—psoriasis	0.000774	0.000862	CcSEcCtD
Amoxapine—Paraesthesia—Hydrocortisone—psoriasis	0.000769	0.000857	CcSEcCtD
Amoxapine—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000769	0.000856	CcSEcCtD
Amoxapine—Urticaria—Cyclosporine—psoriasis	0.000765	0.000853	CcSEcCtD
Amoxapine—Abdominal pain—Cyclosporine—psoriasis	0.000762	0.000849	CcSEcCtD
Amoxapine—Body temperature increased—Cyclosporine—psoriasis	0.000762	0.000849	CcSEcCtD
Amoxapine—Vomiting—Mycophenolic acid—psoriasis	0.000757	0.000844	CcSEcCtD
Amoxapine—Dyspepsia—Hydrocortisone—psoriasis	0.000754	0.00084	CcSEcCtD
Amoxapine—Rash—Mycophenolic acid—psoriasis	0.000751	0.000837	CcSEcCtD
Amoxapine—Dermatitis—Mycophenolic acid—psoriasis	0.00075	0.000836	CcSEcCtD
Amoxapine—Hepatitis—Methotrexate—psoriasis	0.00075	0.000835	CcSEcCtD
Amoxapine—Urticaria—Mycophenolate mofetil—psoriasis	0.000747	0.000832	CcSEcCtD
Amoxapine—Headache—Mycophenolic acid—psoriasis	0.000746	0.000831	CcSEcCtD
Amoxapine—Decreased appetite—Hydrocortisone—psoriasis	0.000744	0.000829	CcSEcCtD
Amoxapine—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000743	0.000828	CcSEcCtD
Amoxapine—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000743	0.000828	CcSEcCtD
Amoxapine—Fatigue—Hydrocortisone—psoriasis	0.000738	0.000823	CcSEcCtD
Amoxapine—Vision blurred—Prednisone—psoriasis	0.000736	0.00082	CcSEcCtD
Amoxapine—Oedema—Betamethasone—psoriasis	0.000732	0.000815	CcSEcCtD
Amoxapine—Oedema—Dexamethasone—psoriasis	0.000732	0.000815	CcSEcCtD
Amoxapine—Insomnia—Triamcinolone—psoriasis	0.000729	0.000813	CcSEcCtD
Amoxapine—Paraesthesia—Triamcinolone—psoriasis	0.000724	0.000807	CcSEcCtD
Amoxapine—Feeling abnormal—Prednisolone—psoriasis	0.000723	0.000805	CcSEcCtD
Amoxapine—Shock—Betamethasone—psoriasis	0.00072	0.000802	CcSEcCtD
Amoxapine—Shock—Dexamethasone—psoriasis	0.00072	0.000802	CcSEcCtD
Amoxapine—Agitation—Prednisone—psoriasis	0.000717	0.000799	CcSEcCtD
Amoxapine—Thrombocytopenia—Dexamethasone—psoriasis	0.000716	0.000798	CcSEcCtD
Amoxapine—Thrombocytopenia—Betamethasone—psoriasis	0.000716	0.000798	CcSEcCtD
Amoxapine—Tachycardia—Dexamethasone—psoriasis	0.000714	0.000796	CcSEcCtD
Amoxapine—Tachycardia—Betamethasone—psoriasis	0.000714	0.000796	CcSEcCtD
Amoxapine—Dyspepsia—Triamcinolone—psoriasis	0.00071	0.000791	CcSEcCtD
Amoxapine—Nausea—Mycophenolic acid—psoriasis	0.000707	0.000788	CcSEcCtD
Amoxapine—Feeling abnormal—Hydrocortisone—psoriasis	0.000706	0.000786	CcSEcCtD
Amoxapine—Gastrointestinal pain—Hydrocortisone—psoriasis	0.0007	0.00078	CcSEcCtD
Amoxapine—Syncope—Prednisone—psoriasis	0.0007	0.00078	CcSEcCtD
Amoxapine—Tinnitus—Methotrexate—psoriasis	0.000699	0.000779	CcSEcCtD
Amoxapine—Anorexia—Betamethasone—psoriasis	0.000697	0.000777	CcSEcCtD
Amoxapine—Anorexia—Dexamethasone—psoriasis	0.000697	0.000777	CcSEcCtD
Amoxapine—Urticaria—Prednisolone—psoriasis	0.000697	0.000776	CcSEcCtD
Amoxapine—Fatigue—Triamcinolone—psoriasis	0.000695	0.000775	CcSEcCtD
Amoxapine—Asthenia—Cyclosporine—psoriasis	0.000691	0.00077	CcSEcCtD
Amoxapine—Loss of consciousness—Prednisone—psoriasis	0.000686	0.000764	CcSEcCtD
Amoxapine—Hypotension—Dexamethasone—psoriasis	0.000684	0.000762	CcSEcCtD
Amoxapine—Hypotension—Betamethasone—psoriasis	0.000684	0.000762	CcSEcCtD
Amoxapine—Pruritus—Cyclosporine—psoriasis	0.000682	0.00076	CcSEcCtD
Amoxapine—Urticaria—Hydrocortisone—psoriasis	0.00068	0.000758	CcSEcCtD
Amoxapine—Abdominal pain—Hydrocortisone—psoriasis	0.000677	0.000754	CcSEcCtD
Amoxapine—Body temperature increased—Hydrocortisone—psoriasis	0.000677	0.000754	CcSEcCtD
Amoxapine—Convulsion—Prednisone—psoriasis	0.000676	0.000754	CcSEcCtD
Amoxapine—Asthenia—Mycophenolate mofetil—psoriasis	0.000674	0.000751	CcSEcCtD
Amoxapine—Hypertension—Prednisone—psoriasis	0.000674	0.000751	CcSEcCtD
Amoxapine—Pruritus—Mycophenolate mofetil—psoriasis	0.000665	0.000741	CcSEcCtD
Amoxapine—Feeling abnormal—Triamcinolone—psoriasis	0.000664	0.00074	CcSEcCtD
Amoxapine—Alopecia—Methotrexate—psoriasis	0.000662	0.000738	CcSEcCtD
Amoxapine—Insomnia—Dexamethasone—psoriasis	0.000662	0.000737	CcSEcCtD
Amoxapine—Insomnia—Betamethasone—psoriasis	0.000662	0.000737	CcSEcCtD
Amoxapine—Diarrhoea—Cyclosporine—psoriasis	0.000659	0.000735	CcSEcCtD
Amoxapine—Paraesthesia—Dexamethasone—psoriasis	0.000657	0.000732	CcSEcCtD
Amoxapine—Paraesthesia—Betamethasone—psoriasis	0.000657	0.000732	CcSEcCtD
Amoxapine—Dyspepsia—Dexamethasone—psoriasis	0.000644	0.000718	CcSEcCtD
Amoxapine—Dyspepsia—Betamethasone—psoriasis	0.000644	0.000718	CcSEcCtD
Amoxapine—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000643	0.000717	CcSEcCtD
Amoxapine—Urticaria—Triamcinolone—psoriasis	0.000641	0.000714	CcSEcCtD
Amoxapine—Dysgeusia—Methotrexate—psoriasis	0.000639	0.000712	CcSEcCtD
Amoxapine—Body temperature increased—Triamcinolone—psoriasis	0.000637	0.00071	CcSEcCtD
Amoxapine—Dizziness—Cyclosporine—psoriasis	0.000637	0.00071	CcSEcCtD
Amoxapine—Oedema—Prednisone—psoriasis	0.000637	0.00071	CcSEcCtD
Amoxapine—Decreased appetite—Betamethasone—psoriasis	0.000636	0.000709	CcSEcCtD
Amoxapine—Decreased appetite—Dexamethasone—psoriasis	0.000636	0.000709	CcSEcCtD
Amoxapine—Fatigue—Dexamethasone—psoriasis	0.000631	0.000703	CcSEcCtD
Amoxapine—Fatigue—Betamethasone—psoriasis	0.000631	0.000703	CcSEcCtD
Amoxapine—Shock—Prednisone—psoriasis	0.000627	0.000698	CcSEcCtD
Amoxapine—Tachycardia—Prednisone—psoriasis	0.000622	0.000693	CcSEcCtD
Amoxapine—Dizziness—Mycophenolate mofetil—psoriasis	0.000622	0.000693	CcSEcCtD
Amoxapine—Vision blurred—Methotrexate—psoriasis	0.000615	0.000685	CcSEcCtD
Amoxapine—Asthenia—Hydrocortisone—psoriasis	0.000614	0.000685	CcSEcCtD
Amoxapine—Vomiting—Cyclosporine—psoriasis	0.000613	0.000683	CcSEcCtD
Amoxapine—Rash—Cyclosporine—psoriasis	0.000608	0.000677	CcSEcCtD
Amoxapine—Anorexia—Prednisone—psoriasis	0.000607	0.000677	CcSEcCtD
Amoxapine—Dermatitis—Cyclosporine—psoriasis	0.000607	0.000676	CcSEcCtD
Amoxapine—Pruritus—Hydrocortisone—psoriasis	0.000606	0.000675	CcSEcCtD
Amoxapine—Headache—Cyclosporine—psoriasis	0.000604	0.000673	CcSEcCtD
Amoxapine—Feeling abnormal—Betamethasone—psoriasis	0.000603	0.000672	CcSEcCtD
Amoxapine—Feeling abnormal—Dexamethasone—psoriasis	0.000603	0.000672	CcSEcCtD
Amoxapine—Gastrointestinal pain—Betamethasone—psoriasis	0.000598	0.000667	CcSEcCtD
Amoxapine—Gastrointestinal pain—Dexamethasone—psoriasis	0.000598	0.000667	CcSEcCtD
Amoxapine—Vomiting—Mycophenolate mofetil—psoriasis	0.000598	0.000666	CcSEcCtD
Amoxapine—Rash—Mycophenolate mofetil—psoriasis	0.000593	0.00066	CcSEcCtD
Amoxapine—Dermatitis—Mycophenolate mofetil—psoriasis	0.000592	0.00066	CcSEcCtD
Amoxapine—Headache—Mycophenolate mofetil—psoriasis	0.000589	0.000656	CcSEcCtD
Amoxapine—Diarrhoea—Hydrocortisone—psoriasis	0.000586	0.000653	CcSEcCtD
Amoxapine—Leukopenia—Methotrexate—psoriasis	0.000584	0.000651	CcSEcCtD
Amoxapine—Urticaria—Betamethasone—psoriasis	0.000581	0.000648	CcSEcCtD
Amoxapine—Urticaria—Dexamethasone—psoriasis	0.000581	0.000648	CcSEcCtD
Amoxapine—Dizziness—Prednisolone—psoriasis	0.00058	0.000646	CcSEcCtD
Amoxapine—Asthenia—Triamcinolone—psoriasis	0.000579	0.000645	CcSEcCtD
Amoxapine—Body temperature increased—Dexamethasone—psoriasis	0.000578	0.000644	CcSEcCtD
Amoxapine—Body temperature increased—Betamethasone—psoriasis	0.000578	0.000644	CcSEcCtD
Amoxapine—Abdominal pain—Betamethasone—psoriasis	0.000578	0.000644	CcSEcCtD
Amoxapine—Abdominal pain—Dexamethasone—psoriasis	0.000578	0.000644	CcSEcCtD
Amoxapine—Insomnia—Prednisone—psoriasis	0.000576	0.000642	CcSEcCtD
Amoxapine—Nausea—Cyclosporine—psoriasis	0.000572	0.000638	CcSEcCtD
Amoxapine—Paraesthesia—Prednisone—psoriasis	0.000572	0.000637	CcSEcCtD
Amoxapine—Pruritus—Triamcinolone—psoriasis	0.00057	0.000636	CcSEcCtD
Amoxapine—Dizziness—Hydrocortisone—psoriasis	0.000566	0.000631	CcSEcCtD
Amoxapine—Convulsion—Methotrexate—psoriasis	0.000565	0.00063	CcSEcCtD
Amoxapine—Dyspepsia—Prednisone—psoriasis	0.000561	0.000625	CcSEcCtD
Amoxapine—Nausea—Mycophenolate mofetil—psoriasis	0.000558	0.000622	CcSEcCtD
Amoxapine—Decreased appetite—Prednisone—psoriasis	0.000554	0.000617	CcSEcCtD
Amoxapine—Rash—Prednisolone—psoriasis	0.000553	0.000616	CcSEcCtD
Amoxapine—Dermatitis—Prednisolone—psoriasis	0.000552	0.000615	CcSEcCtD
Amoxapine—Fatigue—Prednisone—psoriasis	0.000549	0.000612	CcSEcCtD
Amoxapine—Headache—Prednisolone—psoriasis	0.000549	0.000612	CcSEcCtD
Amoxapine—Constipation—Prednisone—psoriasis	0.000545	0.000607	CcSEcCtD
Amoxapine—Vomiting—Hydrocortisone—psoriasis	0.000544	0.000607	CcSEcCtD
Amoxapine—Rash—Hydrocortisone—psoriasis	0.00054	0.000602	CcSEcCtD
Amoxapine—Dermatitis—Hydrocortisone—psoriasis	0.000539	0.000601	CcSEcCtD
Amoxapine—Confusional state—Methotrexate—psoriasis	0.000537	0.000598	CcSEcCtD
Amoxapine—Headache—Hydrocortisone—psoriasis	0.000536	0.000598	CcSEcCtD
Amoxapine—Dizziness—Triamcinolone—psoriasis	0.000533	0.000594	CcSEcCtD
Amoxapine—Feeling abnormal—Prednisone—psoriasis	0.000525	0.000585	CcSEcCtD
Amoxapine—Asthenia—Betamethasone—psoriasis	0.000525	0.000585	CcSEcCtD
Amoxapine—Asthenia—Dexamethasone—psoriasis	0.000525	0.000585	CcSEcCtD
Amoxapine—Thrombocytopenia—Methotrexate—psoriasis	0.000521	0.000581	CcSEcCtD
Amoxapine—Gastrointestinal pain—Prednisone—psoriasis	0.000521	0.00058	CcSEcCtD
Amoxapine—Nausea—Prednisolone—psoriasis	0.000521	0.00058	CcSEcCtD
Amoxapine—Pruritus—Dexamethasone—psoriasis	0.000518	0.000577	CcSEcCtD
Amoxapine—Pruritus—Betamethasone—psoriasis	0.000518	0.000577	CcSEcCtD
Amoxapine—Vomiting—Triamcinolone—psoriasis	0.000513	0.000571	CcSEcCtD
Amoxapine—Nausea—Hydrocortisone—psoriasis	0.000509	0.000567	CcSEcCtD
Amoxapine—Rash—Triamcinolone—psoriasis	0.000508	0.000566	CcSEcCtD
Amoxapine—Dermatitis—Triamcinolone—psoriasis	0.000508	0.000566	CcSEcCtD
Amoxapine—Anorexia—Methotrexate—psoriasis	0.000508	0.000565	CcSEcCtD
Amoxapine—Urticaria—Prednisone—psoriasis	0.000506	0.000564	CcSEcCtD
Amoxapine—Headache—Triamcinolone—psoriasis	0.000505	0.000563	CcSEcCtD
Amoxapine—Abdominal pain—Prednisone—psoriasis	0.000504	0.000561	CcSEcCtD
Amoxapine—Body temperature increased—Prednisone—psoriasis	0.000504	0.000561	CcSEcCtD
Amoxapine—Diarrhoea—Dexamethasone—psoriasis	0.000501	0.000558	CcSEcCtD
Amoxapine—Diarrhoea—Betamethasone—psoriasis	0.000501	0.000558	CcSEcCtD
Amoxapine—Hypotension—Methotrexate—psoriasis	0.000498	0.000554	CcSEcCtD
Amoxapine—Dizziness—Betamethasone—psoriasis	0.000484	0.000539	CcSEcCtD
Amoxapine—Dizziness—Dexamethasone—psoriasis	0.000484	0.000539	CcSEcCtD
Amoxapine—Insomnia—Methotrexate—psoriasis	0.000482	0.000537	CcSEcCtD
Amoxapine—Nausea—Triamcinolone—psoriasis	0.000479	0.000534	CcSEcCtD
Amoxapine—Paraesthesia—Methotrexate—psoriasis	0.000478	0.000533	CcSEcCtD
Amoxapine—Somnolence—Methotrexate—psoriasis	0.000473	0.000527	CcSEcCtD
Amoxapine—Dyspepsia—Methotrexate—psoriasis	0.000469	0.000522	CcSEcCtD
Amoxapine—Vomiting—Dexamethasone—psoriasis	0.000465	0.000518	CcSEcCtD
Amoxapine—Vomiting—Betamethasone—psoriasis	0.000465	0.000518	CcSEcCtD
Amoxapine—Decreased appetite—Methotrexate—psoriasis	0.000463	0.000516	CcSEcCtD
Amoxapine—Rash—Betamethasone—psoriasis	0.000461	0.000514	CcSEcCtD
Amoxapine—Rash—Dexamethasone—psoriasis	0.000461	0.000514	CcSEcCtD
Amoxapine—Dermatitis—Betamethasone—psoriasis	0.000461	0.000513	CcSEcCtD
Amoxapine—Dermatitis—Dexamethasone—psoriasis	0.000461	0.000513	CcSEcCtD
Amoxapine—Fatigue—Methotrexate—psoriasis	0.000459	0.000511	CcSEcCtD
Amoxapine—Headache—Dexamethasone—psoriasis	0.000458	0.000511	CcSEcCtD
Amoxapine—Headache—Betamethasone—psoriasis	0.000458	0.000511	CcSEcCtD
Amoxapine—Asthenia—Prednisone—psoriasis	0.000457	0.000509	CcSEcCtD
Amoxapine—Pruritus—Prednisone—psoriasis	0.000451	0.000502	CcSEcCtD
Amoxapine—Feeling abnormal—Methotrexate—psoriasis	0.000439	0.000489	CcSEcCtD
Amoxapine—Diarrhoea—Prednisone—psoriasis	0.000436	0.000486	CcSEcCtD
Amoxapine—Gastrointestinal pain—Methotrexate—psoriasis	0.000435	0.000485	CcSEcCtD
Amoxapine—Nausea—Dexamethasone—psoriasis	0.000435	0.000484	CcSEcCtD
Amoxapine—Nausea—Betamethasone—psoriasis	0.000435	0.000484	CcSEcCtD
Amoxapine—Urticaria—Methotrexate—psoriasis	0.000423	0.000471	CcSEcCtD
Amoxapine—Dizziness—Prednisone—psoriasis	0.000421	0.000469	CcSEcCtD
Amoxapine—Abdominal pain—Methotrexate—psoriasis	0.000421	0.000469	CcSEcCtD
Amoxapine—Body temperature increased—Methotrexate—psoriasis	0.000421	0.000469	CcSEcCtD
Amoxapine—Vomiting—Prednisone—psoriasis	0.000405	0.000451	CcSEcCtD
Amoxapine—Rash—Prednisone—psoriasis	0.000402	0.000448	CcSEcCtD
Amoxapine—Dermatitis—Prednisone—psoriasis	0.000401	0.000447	CcSEcCtD
Amoxapine—Headache—Prednisone—psoriasis	0.000399	0.000445	CcSEcCtD
Amoxapine—Asthenia—Methotrexate—psoriasis	0.000382	0.000426	CcSEcCtD
Amoxapine—Nausea—Prednisone—psoriasis	0.000378	0.000422	CcSEcCtD
Amoxapine—Pruritus—Methotrexate—psoriasis	0.000377	0.00042	CcSEcCtD
Amoxapine—Diarrhoea—Methotrexate—psoriasis	0.000364	0.000406	CcSEcCtD
Amoxapine—Dizziness—Methotrexate—psoriasis	0.000352	0.000392	CcSEcCtD
Amoxapine—Vomiting—Methotrexate—psoriasis	0.000339	0.000377	CcSEcCtD
Amoxapine—Rash—Methotrexate—psoriasis	0.000336	0.000374	CcSEcCtD
Amoxapine—Dermatitis—Methotrexate—psoriasis	0.000335	0.000374	CcSEcCtD
Amoxapine—Headache—Methotrexate—psoriasis	0.000334	0.000372	CcSEcCtD
Amoxapine—Nausea—Methotrexate—psoriasis	0.000316	0.000352	CcSEcCtD
Amoxapine—HTR6—GPCR downstream signaling—CXCL8—psoriasis	4.14e-05	0.000404	CbGpPWpGaD
Amoxapine—HTR7—GPCR downstream signaling—CXCL8—psoriasis	4.14e-05	0.000404	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—SOCS1—psoriasis	4.14e-05	0.000404	CbGpPWpGaD
Amoxapine—DRD4—Signaling by GPCR—TYK2—psoriasis	4.13e-05	0.000403	CbGpPWpGaD
Amoxapine—HTR1B—GPCR downstream signaling—CXCL8—psoriasis	4.02e-05	0.000393	CbGpPWpGaD
Amoxapine—DRD4—GPCR downstream signaling—CXCL8—psoriasis	3.96e-05	0.000387	CbGpPWpGaD
Amoxapine—HTR2B—Signaling by GPCR—TYK2—psoriasis	3.94e-05	0.000385	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—SOCS1—psoriasis	3.9e-05	0.000381	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—SOCS1—psoriasis	3.85e-05	0.000376	CbGpPWpGaD
Amoxapine—HTR2B—GPCR downstream signaling—CXCL8—psoriasis	3.78e-05	0.000369	CbGpPWpGaD
Amoxapine—HTR6—Signaling by GPCR—CXCL8—psoriasis	3.76e-05	0.000367	CbGpPWpGaD
Amoxapine—HTR7—Signaling by GPCR—CXCL8—psoriasis	3.76e-05	0.000367	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—CXCL8—psoriasis	3.74e-05	0.000365	CbGpPWpGaD
Amoxapine—DRD1—Signaling by GPCR—TYK2—psoriasis	3.72e-05	0.000363	CbGpPWpGaD
Amoxapine—DRD3—Signaling by GPCR—TYK2—psoriasis	3.67e-05	0.000358	CbGpPWpGaD
Amoxapine—HTR1B—Signaling by GPCR—CXCL8—psoriasis	3.65e-05	0.000357	CbGpPWpGaD
Amoxapine—DRD4—Signaling by GPCR—CXCL8—psoriasis	3.6e-05	0.000351	CbGpPWpGaD
Amoxapine—DRD1—GPCR downstream signaling—CXCL8—psoriasis	3.57e-05	0.000348	CbGpPWpGaD
Amoxapine—HRH4—Signaling by GPCR—IL6—psoriasis	3.55e-05	0.000347	CbGpPWpGaD
Amoxapine—DRD3—GPCR downstream signaling—CXCL8—psoriasis	3.52e-05	0.000343	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—JUN—psoriasis	3.47e-05	0.000339	CbGpPWpGaD
Amoxapine—HTR2B—Signaling by GPCR—CXCL8—psoriasis	3.43e-05	0.000335	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—SOCS1—psoriasis	3.35e-05	0.000327	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—NFKB1—psoriasis	3.34e-05	0.000326	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—APOE—psoriasis	3.34e-05	0.000326	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—LEP—psoriasis	3.34e-05	0.000326	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—LEP—psoriasis	3.34e-05	0.000326	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—APOE—psoriasis	3.34e-05	0.000326	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—SOCS1—psoriasis	3.34e-05	0.000326	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—LEP—psoriasis	3.25e-05	0.000317	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—APOE—psoriasis	3.25e-05	0.000317	CbGpPWpGaD
Amoxapine—DRD1—Signaling by GPCR—CXCL8—psoriasis	3.24e-05	0.000316	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—TYK2—psoriasis	3.2e-05	0.000312	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—LEP—psoriasis	3.2e-05	0.000312	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—APOE—psoriasis	3.2e-05	0.000312	CbGpPWpGaD
Amoxapine—DRD3—Signaling by GPCR—CXCL8—psoriasis	3.19e-05	0.000312	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—TYK2—psoriasis	3.18e-05	0.000311	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—CARM1—psoriasis	3.17e-05	0.00031	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—NFKBIA—psoriasis	3.12e-05	0.000304	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—NFKBIA—psoriasis	3.11e-05	0.000304	CbGpPWpGaD
Amoxapine—ADRA2A—Hemostasis—VEGFA—psoriasis	3.1e-05	0.000302	CbGpPWpGaD
Amoxapine—HTR1A—GPCR downstream signaling—CXCL8—psoriasis	3.07e-05	0.000299	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—APOE—psoriasis	3.05e-05	0.000298	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—LEP—psoriasis	3.05e-05	0.000298	CbGpPWpGaD
Amoxapine—HTR2C—GPCR downstream signaling—CXCL8—psoriasis	3.05e-05	0.000298	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—VEGFA—psoriasis	3.03e-05	0.000296	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—NFKBIA—psoriasis	3.03e-05	0.000296	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—STAT3—psoriasis	3e-05	0.000293	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—CAT—psoriasis	2.99e-05	0.000292	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—NFKBIA—psoriasis	2.98e-05	0.000291	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—SOCS1—psoriasis	2.94e-05	0.000288	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—SOCS1—psoriasis	2.9e-05	0.000283	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—SOCS1—psoriasis	2.89e-05	0.000282	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—SOCS1—psoriasis	2.88e-05	0.000281	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—APOE—psoriasis	2.88e-05	0.000281	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—LEP—psoriasis	2.88e-05	0.000281	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—NFKBIA—psoriasis	2.84e-05	0.000278	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—APOE—psoriasis	2.84e-05	0.000277	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—LEP—psoriasis	2.84e-05	0.000277	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—SOCS1—psoriasis	2.84e-05	0.000277	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—TYK2—psoriasis	2.81e-05	0.000274	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—CXCL8—psoriasis	2.78e-05	0.000272	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—CXCL8—psoriasis	2.77e-05	0.00027	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—TYK2—psoriasis	2.76e-05	0.00027	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—TYK2—psoriasis	2.76e-05	0.000269	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—TYK2—psoriasis	2.75e-05	0.000268	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—TYK2—psoriasis	2.7e-05	0.000264	CbGpPWpGaD
Amoxapine—DRD2—GPCR downstream signaling—CXCL8—psoriasis	2.69e-05	0.000263	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—NFKBIA—psoriasis	2.68e-05	0.000262	CbGpPWpGaD
Amoxapine—HTR2A—GPCR downstream signaling—CXCL8—psoriasis	2.65e-05	0.000259	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—NFKBIA—psoriasis	2.65e-05	0.000258	CbGpPWpGaD
Amoxapine—HRH1—GPCR downstream signaling—CXCL8—psoriasis	2.64e-05	0.000258	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—SOCS1—psoriasis	2.64e-05	0.000257	CbGpPWpGaD
Amoxapine—CHRM1—GPCR downstream signaling—CXCL8—psoriasis	2.63e-05	0.000257	CbGpPWpGaD
Amoxapine—ADRA1A—GPCR downstream signaling—CXCL8—psoriasis	2.59e-05	0.000253	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—TYK2—psoriasis	2.55e-05	0.000249	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—TYK2—psoriasis	2.55e-05	0.000249	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—TYK2—psoriasis	2.51e-05	0.000245	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—TYK2—psoriasis	2.48e-05	0.000242	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—LEP—psoriasis	2.47e-05	0.000242	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—APOE—psoriasis	2.47e-05	0.000242	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—LEP—psoriasis	2.46e-05	0.00024	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—APOE—psoriasis	2.46e-05	0.00024	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—CXCL8—psoriasis	2.44e-05	0.000239	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—TYK2—psoriasis	2.44e-05	0.000238	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR downstream signaling—CXCL8—psoriasis	2.41e-05	0.000235	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—CXCL8—psoriasis	2.41e-05	0.000235	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—CXCL8—psoriasis	2.4e-05	0.000234	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—CXCL8—psoriasis	2.39e-05	0.000234	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—CXCL8—psoriasis	2.35e-05	0.00023	CbGpPWpGaD
Amoxapine—ADRA2A—Hemostasis—TP53—psoriasis	2.34e-05	0.000228	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—TYK2—psoriasis	2.33e-05	0.000227	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—APOE—psoriasis	2.33e-05	0.000227	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—NFKBIA—psoriasis	2.31e-05	0.000225	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—NFKBIA—psoriasis	2.29e-05	0.000224	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—TP53—psoriasis	2.29e-05	0.000224	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—CXCL8—psoriasis	2.22e-05	0.000217	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—CXCL8—psoriasis	2.22e-05	0.000217	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—TYK2—psoriasis	2.2e-05	0.000214	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—CXCL8—psoriasis	2.19e-05	0.000214	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—LEP—psoriasis	2.17e-05	0.000212	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—APOE—psoriasis	2.17e-05	0.000212	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—TYK2—psoriasis	2.17e-05	0.000212	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—CXCL8—psoriasis	2.16e-05	0.000211	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—APOE—psoriasis	2.14e-05	0.000209	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—LEP—psoriasis	2.14e-05	0.000209	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—LEP—psoriasis	2.13e-05	0.000208	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—APOE—psoriasis	2.13e-05	0.000208	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—LEP—psoriasis	2.13e-05	0.000208	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—APOE—psoriasis	2.13e-05	0.000208	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—CXCL8—psoriasis	2.12e-05	0.000207	CbGpPWpGaD
Amoxapine—HTR6—Signaling by GPCR—IL6—psoriasis	2.11e-05	0.000206	CbGpPWpGaD
Amoxapine—HTR7—Signaling by GPCR—IL6—psoriasis	2.11e-05	0.000206	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—IL6—psoriasis	2.1e-05	0.000205	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—APOE—psoriasis	2.09e-05	0.000204	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—LEP—psoriasis	2.09e-05	0.000204	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—JUN—psoriasis	2.07e-05	0.000202	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—JUN—psoriasis	2.06e-05	0.000201	CbGpPWpGaD
Amoxapine—HTR1B—Signaling by GPCR—IL6—psoriasis	2.05e-05	0.0002	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—CXCL8—psoriasis	2.03e-05	0.000198	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—PPARG—psoriasis	2.03e-05	0.000198	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—NFKBIA—psoriasis	2.02e-05	0.000198	CbGpPWpGaD
Amoxapine—DRD4—Signaling by GPCR—IL6—psoriasis	2.02e-05	0.000197	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—JUN—psoriasis	2.01e-05	0.000196	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—NFKBIA—psoriasis	1.99e-05	0.000195	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—NFKB1—psoriasis	1.99e-05	0.000194	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—NFKBIA—psoriasis	1.99e-05	0.000194	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—NFKB1—psoriasis	1.99e-05	0.000194	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—NFKBIA—psoriasis	1.98e-05	0.000193	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—JUN—psoriasis	1.97e-05	0.000193	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—CAT—psoriasis	1.95e-05	0.00019	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—NFKBIA—psoriasis	1.95e-05	0.00019	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—APOE—psoriasis	1.95e-05	0.00019	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—LEP—psoriasis	1.95e-05	0.00019	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—NFKB1—psoriasis	1.93e-05	0.000189	CbGpPWpGaD
Amoxapine—HTR2B—Signaling by GPCR—IL6—psoriasis	1.93e-05	0.000188	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—CXCL8—psoriasis	1.91e-05	0.000187	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—NFKB1—psoriasis	1.9e-05	0.000186	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—TYK2—psoriasis	1.89e-05	0.000184	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—CXCL8—psoriasis	1.89e-05	0.000184	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—JUN—psoriasis	1.89e-05	0.000184	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—TYK2—psoriasis	1.88e-05	0.000183	CbGpPWpGaD
Amoxapine—DRD1—Signaling by GPCR—IL6—psoriasis	1.82e-05	0.000178	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—NFKB1—psoriasis	1.81e-05	0.000177	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—NFKBIA—psoriasis	1.81e-05	0.000177	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—VEGFA—psoriasis	1.8e-05	0.000176	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—VEGFA—psoriasis	1.8e-05	0.000176	CbGpPWpGaD
Amoxapine—DRD3—Signaling by GPCR—IL6—psoriasis	1.79e-05	0.000175	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—STAT3—psoriasis	1.79e-05	0.000174	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—STAT3—psoriasis	1.78e-05	0.000174	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—JUN—psoriasis	1.78e-05	0.000174	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—JUN—psoriasis	1.75e-05	0.000171	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—VEGFA—psoriasis	1.75e-05	0.000171	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—STAT3—psoriasis	1.74e-05	0.00017	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—VEGFA—psoriasis	1.73e-05	0.000168	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—NFKB1—psoriasis	1.71e-05	0.000167	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—STAT3—psoriasis	1.71e-05	0.000167	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—NFKB1—psoriasis	1.69e-05	0.000165	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—TYK2—psoriasis	1.66e-05	0.000162	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—VEGFA—psoriasis	1.65e-05	0.000161	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—CXCL8—psoriasis	1.64e-05	0.000161	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—CXCL8—psoriasis	1.64e-05	0.00016	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—TYK2—psoriasis	1.63e-05	0.000159	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—STAT3—psoriasis	1.63e-05	0.000159	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—TYK2—psoriasis	1.63e-05	0.000159	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—TYK2—psoriasis	1.62e-05	0.000158	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—TYK2—psoriasis	1.6e-05	0.000156	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—IL6—psoriasis	1.56e-05	0.000153	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—IL6—psoriasis	1.56e-05	0.000152	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—VEGFA—psoriasis	1.55e-05	0.000152	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—STAT3—psoriasis	1.54e-05	0.00015	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—VEGFA—psoriasis	1.53e-05	0.00015	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—JUN—psoriasis	1.53e-05	0.000149	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—JUN—psoriasis	1.52e-05	0.000149	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—STAT3—psoriasis	1.52e-05	0.000148	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—APOE—psoriasis	1.52e-05	0.000148	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—TYK2—psoriasis	1.48e-05	0.000145	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—NFKB1—psoriasis	1.47e-05	0.000144	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—NFKB1—psoriasis	1.46e-05	0.000143	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CXCL8—psoriasis	1.44e-05	0.000141	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CXCL8—psoriasis	1.42e-05	0.000139	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CXCL8—psoriasis	1.42e-05	0.000138	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CXCL8—psoriasis	1.41e-05	0.000138	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CXCL8—psoriasis	1.39e-05	0.000136	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—IL6—psoriasis	1.37e-05	0.000134	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—TP53—psoriasis	1.36e-05	0.000133	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—TP53—psoriasis	1.36e-05	0.000133	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—IL6—psoriasis	1.35e-05	0.000132	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—IL6—psoriasis	1.35e-05	0.000132	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—IL6—psoriasis	1.34e-05	0.000131	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—JUN—psoriasis	1.34e-05	0.000131	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—VEGFA—psoriasis	1.34e-05	0.00013	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—VEGFA—psoriasis	1.33e-05	0.00013	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—TP53—psoriasis	1.32e-05	0.000129	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—IL6—psoriasis	1.32e-05	0.000129	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—STAT3—psoriasis	1.32e-05	0.000129	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—JUN—psoriasis	1.32e-05	0.000129	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PPARG—psoriasis	1.32e-05	0.000129	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—JUN—psoriasis	1.32e-05	0.000129	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—STAT3—psoriasis	1.32e-05	0.000128	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—JUN—psoriasis	1.31e-05	0.000128	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—TP53—psoriasis	1.3e-05	0.000127	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—JUN—psoriasis	1.29e-05	0.000126	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CXCL8—psoriasis	1.29e-05	0.000126	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—NFKB1—psoriasis	1.29e-05	0.000126	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—NFKB1—psoriasis	1.27e-05	0.000124	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—NFKB1—psoriasis	1.27e-05	0.000124	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—NFKB1—psoriasis	1.26e-05	0.000123	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—IL6—psoriasis	1.25e-05	0.000122	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—IL6—psoriasis	1.25e-05	0.000122	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—NFKB1—psoriasis	1.24e-05	0.000122	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—TP53—psoriasis	1.24e-05	0.000122	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—IL6—psoriasis	1.23e-05	0.00012	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—IL6—psoriasis	1.21e-05	0.000118	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—JUN—psoriasis	1.2e-05	0.000117	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—IL6—psoriasis	1.19e-05	0.000117	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—TP53—psoriasis	1.17e-05	0.000115	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—VEGFA—psoriasis	1.17e-05	0.000115	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—STAT3—psoriasis	1.16e-05	0.000113	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—TP53—psoriasis	1.16e-05	0.000113	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—NFKB1—psoriasis	1.16e-05	0.000113	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—VEGFA—psoriasis	1.15e-05	0.000113	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—VEGFA—psoriasis	1.15e-05	0.000112	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—VEGFA—psoriasis	1.15e-05	0.000112	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—STAT3—psoriasis	1.14e-05	0.000112	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—STAT3—psoriasis	1.14e-05	0.000111	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—IL6—psoriasis	1.14e-05	0.000111	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—STAT3—psoriasis	1.14e-05	0.000111	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—VEGFA—psoriasis	1.13e-05	0.00011	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—STAT3—psoriasis	1.12e-05	0.000109	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—IL6—psoriasis	1.07e-05	0.000105	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—IL6—psoriasis	1.06e-05	0.000104	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—VEGFA—psoriasis	1.05e-05	0.000103	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—STAT3—psoriasis	1.04e-05	0.000102	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—TP53—psoriasis	1.01e-05	9.86e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—TP53—psoriasis	1e-05	9.8e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—IL6—psoriasis	9.24e-06	9.02e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—IL6—psoriasis	9.19e-06	8.97e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—TP53—psoriasis	8.86e-06	8.65e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—TP53—psoriasis	8.72e-06	8.51e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—TP53—psoriasis	8.7e-06	8.5e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—TP53—psoriasis	8.67e-06	8.47e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—TP53—psoriasis	8.54e-06	8.34e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—IL6—psoriasis	8.11e-06	7.92e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—IL6—psoriasis	7.98e-06	7.79e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—IL6—psoriasis	7.96e-06	7.78e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—IL6—psoriasis	7.94e-06	7.75e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—TP53—psoriasis	7.93e-06	7.75e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—IL6—psoriasis	7.81e-06	7.63e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—IL6—psoriasis	7.26e-06	7.09e-05	CbGpPWpGaD
